Clincosm LogoSign in Get a demo

Recurrent Prostate Carcinoma

Showing 26 - 49 of 49
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in Los Angeles (radiation, other, procedure)

Completed
  • Prostate Adenocarcinoma
  • Recurrent Prostate Carcinoma
  • Gallium Ga 68 Gozetotide
  • +2 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Jun 30, 2021

Hormone-Resistant Prostate Cancer, Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma Trial in Seattle (Abiraterone

Completed
Has Results
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Abiraterone Acetate
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Apr 22, 2021

Castration-Resistant Prostatic Cancer, Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma Trial in United States (GnRH

Recruiting
  • Castration-Resistant Prostatic Cancer
  • +4 more
  • GnRH agonist/antagonist
  • +3 more
  • Los Angeles, California
  • +3 more
Apr 30, 2021

Castration-Resistant Prostate Carcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer AJCC v7 Trial in United States

Completed
Has Results
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Abiraterone Acetate
  • +3 more
  • Duarte, California
  • +13 more
Oct 21, 2020

Recurrent Prostate Carcinoma Trial in Los Angeles (procedure, drug, other)

Completed
  • Recurrent Prostate Carcinoma
  • Computed Tomography
  • +4 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Oct 12, 2020

Drug Resistance in Metastatic Castration-Resistant Prostate

Completed
  • Castration Levels of Testosterone
  • +5 more
  • Cytology Specimen Collection Procedure
  • +2 more
  • Los Angeles, California
  • +2 more
Sep 24, 2020

Recurrent Prostate Carcinoma, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial in New Brunswick (Aspirin, Laboratory

Terminated
  • Recurrent Prostate Carcinoma
  • +4 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Sep 2, 2020

Recurrent Prostate Carcinoma, Stage IV Prostate Cancer AJCC v7 Trial in San Francisco (Ipilimumab, Laboratory Biomarker

Completed
  • Recurrent Prostate Carcinoma
  • Stage IV Prostate Cancer AJCC v7
  • Ipilimumab
  • +3 more
  • San Francisco, California
    UCSF Medical Center-Mount Zion
Jul 29, 2020

Prostate Adenocarcinoma, Recurrent Prostate Carcinoma, Stage I Prostate Adenocarcinoma AJCC v7 Trial in San Francisco

Completed
Has Results
  • Prostate Adenocarcinoma
  • +4 more
  • San Francisco, California
    University of California, San Francisco
Jan 22, 2020

Hormone-Resistant Prostate Cancer, Metastatic Prostatic Adenocarcinoma, Prostate Adenocarcinoma Trial in Portland, Seattle

Terminated
Has Results
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Biopsy of Prostate
  • +3 more
  • Portland, Oregon
  • +2 more
Sep 19, 2019

Hormone-Resistant Prostate Cancer, Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in United States (biological,

Completed
Has Results
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Cixutumumab
  • +2 more
  • Chicago, Illinois
  • +3 more
May 21, 2019

Advanced Malignant Tumor, Cervical Squamous Cell Carcinoma, Endometrial Carcinoma Trial in Scottsdale, Rochester (Laboratory

Completed
  • Advanced Malignant Neoplasm
  • +31 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Scottsdale, Arizona
  • +1 more
Jun 5, 2019

Hormone-Resistant Prostate Cancer, Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in United States (Laboratory

Completed
Has Results
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Washington, District of Columbia
  • +19 more
Aug 13, 2018

Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in Seattle

Completed
  • Castration Levels of Testosterone
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Apr 16, 2018

Recurrent Prostate Carcinoma Trial in Palo Alto (Computed Tomography, Gallium Ga 68-labeled PSMA Ligand Glu-urea-Lys(Ahx),

Completed
Has Results
  • Recurrent Prostate Carcinoma
  • Computed Tomography
  • +3 more
  • Palo Alto, California
    Stanford University, School of Medicine
Feb 20, 2018

Prostate Adenocarcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer Trial in Canada, United States (drug,

Completed
Has Results
  • Prostate Adenocarcinoma
  • +2 more
  • Fairbanks, Alaska
  • +169 more
Feb 23, 2018

Hormone-Resistant Prostate Cancer, Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in United States (drug, other,

Terminated
Has Results
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Jacksonville, Florida
  • +13 more
Aug 21, 2017

Prostate Adenocarcinoma, Recurrent Prostate Carcinoma, Stage III Prostate Cancer Trial in Buffalo (dietary supplement, drug,

Terminated
Has Results
  • Prostate Adenocarcinoma
  • +3 more
  • Calcitriol
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
May 15, 2017

Hormone-Resistant Prostate Cancer, Recurrent Prostate Carcinoma Trial in Canada (Bicalutamide, Laboratory Biomarker Analysis,

Completed
Has Results
  • Hormone-Resistant Prostate Cancer
  • Recurrent Prostate Carcinoma
  • Vancouver, British Columbia, Canada
  • +5 more
Apr 17, 2017

Prostate Adenocarcinoma, Prostate Carcinoma, Recurrent Prostate Carcinoma Trial in Rochester (Bicalutamide, Flutamide, Goserelin

Completed
Has Results
  • Prostate Adenocarcinoma
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic
Apr 6, 2017

Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Buffalo (biological, other, drug)

Completed
  • Anaplastic Astrocytoma
  • +64 more
  • DEC-205/NY-ESO-1 Fusion Protein CDX-1401
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 3, 2016

Hormone-Resistant Prostate Cancer, Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma Trial in Buffalo (other,

Completed
Has Results
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Buffalo, New York
    Roswell Park Cancer Institute
May 19, 2016

Hormone-Resistant Prostate Cancer, Metastatic Malignant Tumor in the Bone, Recurrent Prostate Carcinoma Trial in United States

Completed
Has Results
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Fluorine F 18 Sodium Fluoride
  • Boston, Massachusetts
  • +3 more
Jun 22, 2015

Recurrent Prostate Carcinoma, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial in United States (Bicalutamide, Goserelin

Completed
Has Results
  • Recurrent Prostate Carcinoma
  • +4 more
  • Jacksonville, Florida
  • +6 more
Jun 3, 2015